Andrew C.W. Zannettino - Search Results

Year	Number of Results
2003	6
2004	4
2005	5
2006	5
2007	5
2008	6
2009	11
2010	14
2011	8
2012	4
2013	10
2014	8
2015	10
2016	9
2017	14
2018	12
2019	4
2020	12
2021	10
2022	4
2023	4
2024	3

1

Expression of the chemokine receptor CCR1 decreases sensitivity to bortezomib in multiple myeloma cell lines.

Zeissig MN, Hewett DR, Mrozik KM, Panagopoulos V, Wallington-Gates CT, Spencer A, Dold SM, Engelhardt M, Vandyke K, Zannettino ACW. Zeissig MN, et al. Among authors: zannettino acw. Leuk Res. 2024 Apr;139:107469. doi: 10.1016/j.leukres.2024.107469. Epub 2024 Mar 7. Leuk Res. 2024. PMID: 38479337 Free article.

2

Supporting gut health with medicinal cannabis in people with advanced cancer: potential benefits and challenges.

Wardill HR, Wooley LT, Bellas OM, Cao K, Cross CB, van Dyk M, Kichenadasse G, Bowen JM, Zannettino ACW, Shakib S, Crawford GB, Boublik J, Davis MM, Smid SD, Price TJ. Wardill HR, et al. Among authors: zannettino acw. Br J Cancer. 2024 Jan;130(1):19-30. doi: 10.1038/s41416-023-02466-w. Epub 2023 Oct 26. Br J Cancer. 2024. PMID: 37884682 Free PMC article. Review.

3

More than a small adult brain: Lessons from chemotherapy-induced cognitive impairment for modelling paediatric brain disorders.

Davies MR, Greenberg Z, van Vuurden DG, Cross CB, Zannettino ACW, Bardy C, Wardill HR. Davies MR, et al. Among authors: zannettino acw. Brain Behav Immun. 2024 Jan;115:229-247. doi: 10.1016/j.bbi.2023.10.013. Epub 2023 Oct 18. Brain Behav Immun. 2024. PMID: 37858741 Free article. Review.

4

Myeloperoxidase creates a permissive microenvironmental niche for the progression of multiple myeloma.

Williams CMD, Noll JE, Bradey AL, Duggan J, Wilczek VJ, Masavuli MG, Grubor-Bauk B, Panagopoulos RA, Hewett DR, Mrozik KM, Zannettino ACW, Vandyke K, Panagopoulos V. Williams CMD, et al. Among authors: zannettino acw. Br J Haematol. 2023 Nov;203(4):614-624. doi: 10.1111/bjh.19102. Epub 2023 Sep 12. Br J Haematol. 2023. PMID: 37699574 Free PMC article.

5

Mesenchymal stromal cell senescence in haematological malignancies.

Plakhova N, Panagopoulos V, Vandyke K, Zannettino ACW, Mrozik KM. Plakhova N, et al. Among authors: zannettino acw. Cancer Metastasis Rev. 2023 Mar;42(1):277-296. doi: 10.1007/s10555-022-10069-9. Epub 2023 Jan 9. Cancer Metastasis Rev. 2023. PMID: 36622509 Review.

6

A Thermosensitive, Chitosan-Based Hydrogel as Delivery System for Antibacterial Liposomes to Surgical Site Infections.

Kaul L, Grundmann CE, Köll-Weber M, Löffler H, Weiz A, Zannettino ACW, Richter K, Süss R. Kaul L, et al. Among authors: zannettino acw. Pharmaceutics. 2022 Dec 18;14(12):2841. doi: 10.3390/pharmaceutics14122841. Pharmaceutics. 2022. PMID: 36559332 Free PMC article.

7

The combination of diethyldithiocarbamate and copper ions is active against Staphylococcus aureus and Staphylococcus epidermidis biofilms in vitro and in vivo.

Kaul L, Abdo AI, Coenye T, Krom BP, Hoogenkamp MA, Zannettino ACW, Süss R, Richter K. Kaul L, et al. Among authors: zannettino acw. Front Microbiol. 2022 Sep 9;13:999893. doi: 10.3389/fmicb.2022.999893. eCollection 2022. Front Microbiol. 2022. PMID: 36160243 Free PMC article.

8

Calorie restriction has no effect on bone marrow tumour burden in a Vk*MYC transplant model of multiple myeloma.

Bradey AL, Fitter S, Duggan J, Wilczek V, Williams CMD, Cheney EA, Noll JE, Tangseefa P, Panagopoulos V, Zannettino ACW. Bradey AL, et al. Among authors: zannettino acw. Sci Rep. 2022 Jul 30;12(1):13128. doi: 10.1038/s41598-022-17403-9. Sci Rep. 2022. PMID: 35908046 Free PMC article.

9

Fragmentation of tissue-resident macrophages during isolation confounds analysis of single-cell preparations from mouse hematopoietic tissues.

Millard SM, Heng O, Opperman KS, Sehgal A, Irvine KM, Kaur S, Sandrock CJ, Wu AC, Magor GW, Batoon L, Perkins AC, Noll JE, Zannettino ACW, Sester DP, Levesque JP, Hume DA, Raggatt LJ, Summers KM, Pettit AR. Millard SM, et al. Among authors: zannettino acw. Cell Rep. 2021 Nov 23;37(8):110058. doi: 10.1016/j.celrep.2021.110058. Cell Rep. 2021. PMID: 34818538 Free article.

10

Desmoglein-2 expression is an independent predictor of poor prognosis patients with multiple myeloma.

Ebert LM, Vandyke K, Johan MZ, DeNichilo M, Tan LY, Myo Min KK, Weimann BM, Ebert BW, Pitson SM, Zannettino ACW, Wallington-Beddoe CT, Bonder CS. Ebert LM, et al. Among authors: zannettino acw. Mol Oncol. 2022 Mar;16(6):1221-1240. doi: 10.1002/1878-0261.13055. Epub 2021 Jul 24. Mol Oncol. 2022. PMID: 34245117 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

142 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

142 results

Results by year